The company says its AI and synthetic biology platform can produce compounds not possible with traditional synthesis ...

Gain insights into the U.S. market, valued at $5.9 Billion in 2024, and China, forecasted to grow at an impressive 14.4% CAGR to reach $7.8 Billion by 2030. Discover growth trends in other key regions ...

Eli Lilly is investing $6B in a Huntsville, Ala., plant to make weight-loss and other medicines. Here’s what we know about ...

Ely Lilly’s announcement to invest $6 billion into a manufacturing plant opened up a partnership with the University of ...

Field trials in plant biotechnology are designed to test promising new plants in a situation similar to the actual growing conditions by farmers, such as unpredictable light and temperature, the ...

PREVIOUS COVERAGE - Pharmaceutical giant Eli Lilly and Company announced Tuesday a massive $6 billion investment to build a ...

An enzyme found in papaya could lead to new medicines: a scientific review reveals the surprising pharmaceutical potential of papain.

Eli Lilly said on Tuesday it will invest more than $6 billion in a new active drug ingredient manufacturing facility in Huntsville, Alabama, to expand U.S. production and bolster medicine supply ...

A major pharmaceutical company is making an announcement on Tuesday regarding growth of biopharma innovation in the Rocket ...

The pharmaceutical giant's investment in Huntsville will be a huge boost to the local economy, underscoring its rising ...

Biotechnology can be used in the packaging of beauty products and has a significant sustainability impact that is good for ...

Norfolk Southern will serve a new $6 billion Eli Lilly and Co. manufacturing campus that the pharmaceutical company will ...